SCHEMBL8539779

SCHEMBL8539779

Oc1cccc(C2CCCN2Cc2cccnc2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.60
ALDH1A1 P00352 4/20 0.60
GAA P10253 2/20 0.60
TSHR P16473 1/20 0.60
HTT P42858 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
NPSR1 Q6W5P4 1/20 0.53
POLB P06746 1/20 0.52
OPRK1 P41145 5/20 0.47
OPRM1 P35372 4/20 0.47
OPRD1 P41143 2/20 0.47
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
MEN1 O00255 1/20 0.46
HPGD P15428 1/20 0.46
HRH3 Q9Y5N1 1/20 0.45
TP53 P04637 1/20 0.45
MDM2 Q00987 1/20 0.45
CHRNB2 P17787 2/20 0.45
CHRNA4 P43681 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8540467 0.86 KDM4E (0.52) KDM4EALDH1A1GAATSHRHTT
SCHEMBL8541194 0.85 DRD2 (0.59) KDM4EALDH1A1GAATSHRHTT
SCHEMBL8539612 0.83 KDM4E (0.78) KDM4EALDH1A1GAATSHRHTT
SCHEMBL8539332 0.82 KDM4E (0.53) KDM4EALDH1A1GAATSHRHTT
SCHEMBL29683884 0.80 ALDH1A1 (0.72) KDM4EALDH1A1GAATSHRHTT
SCHEMBL28502868 0.80 ALDH1A1 (0.72) KDM4EALDH1A1GAATSHRHTT
SCHEMBL28503664 0.80 ALDH1A1 (0.72) KDM4EALDH1A1GAATSHRHTT
SCHEMBL28508997 0.80 ALDH1A1 (0.72) KDM4EALDH1A1GAATSHRHTT
SCHEMBL8589940 0.80 ALDH1A1 (0.56) KDM4EALDH1A1GAATSHRHTT
SCHEMBL8542198 0.78 KDM4E (0.57) KDM4EALDH1A1GAATSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0671388-B1 (Pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1998-06-10 EP claimed
US-5591856-A CHEMICAL INTERMEDIATES, TREATMENT OF ALZHEIMER'S DISEASE HOECHST ROUSSEL PHARMACEUTICALS INC. (US) 1997-01-07 US claimed
EP-0671388-A1 (Pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-09-13 EP claimed
EP-0671388-B1 (Pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1998-06-10 EP disclosed
US-5591856-A CHEMICAL INTERMEDIATES, TREATMENT OF ALZHEIMER'S DISEASE HOECHST ROUSSEL PHARMACEUTICALS INC. (US) 1997-01-07 US disclosed
US-5554750-A TO RELIEVE MEMORY DYSFUNCTIONS; TREATMENT OF ALZHEMER*S HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1996-09-10 US disclosed
EP-0671388-A1 (Pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-09-13 EP disclosed
US-5405845-A Administering to relieve memory dysfunction; treatment of Alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1995-04-11 US disclosed
US-5338739-A Memory dysfunction relieving compounds HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-16 US disclosed